AV
Anant Vishwakarma
About Anant Vishwakarma
Data last updated:
Anant Vishwakarma is a Director at Onco-Vac Biopharma Private Limited (since 2022). The company operates in Research & Development. Onco-Vac Biopharma Private Limited reported revenue of ₹28,383 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Nov 2022 | 2022 | ₹28,383 (FY 2025) | Active |
Board colleagues of Anant Vishwakarma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Kumar Vaid | 01272079 | Onco-Vac Biopharma Private Limited | Director |
| Raj Kumar Mallick | 00175869 | Onco-Vac Biopharma Private Limited | Director |
| Ram Vishwakarma Asrey | 07108315 | Onco-Vac Biopharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anant Vishwakarma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anant Vishwakarma
Anant Vishwakarma currently holds 1 directorship: Onco-Vac Biopharma Private Limited (Director, since 14 Nov 2022, revenue ₹28,383 (FY 2025)).
Anant Vishwakarma was first appointed on 14 Nov 2022 as Director at Onco-Vac Biopharma Private Limited.
The current boards of Anant Vishwakarma's companies include Ashok Kumar Vaid (Onco-Vac Biopharma Private Limited), Raj Kumar Mallick (Onco-Vac Biopharma Private Limited), Ram Vishwakarma Asrey (Onco-Vac Biopharma Private Limited).